Not all patients with CLL require therapy. In spite of all modern advances, the iwCLL continue to suggests watchful observation for individuals with asymptomatic disease.86 This suggestion is based on a minimum of two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both equally https://xiaopingg429hqy7.weblogco.com/profile